Literature DB >> 10450884

Cherubism: clinicopathologic features.

T Yamaguchi1, H D Dorfman, S Eisig.   

Abstract

A case of cherubism in 6-year-old boy is reported. He presented with bilateral symmetrical enlargement of the jaw in addition to medially dislocated premature teeth, narrow V-shaped palatal vault, and mild upward turning of the eyes. Radiographs showed multiloculated osteolysis in both the mandible and maxilla. Histology revealed a non-neoplastic fibrous lesion, rich in multinucleated giant cells, consistent with giant-cell reparative granuloma. Since the original description of cherubism, various histologic interpretations have been proposed, particularly that of fibrous dysplasia. However, it should be emphasized that cherubism is a disease histologically indistinguishable from giant-cell reparative granuloma.

Entities:  

Mesh:

Year:  1999        PMID: 10450884     DOI: 10.1007/s002560050530

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  10 in total

1.  [Symmetrical cheek swelling].

Authors:  H Greess; B Lehner; F W Neukam; W Bautz
Journal:  Radiologe       Date:  2002-07       Impact factor: 0.635

2.  Cherubism associated with neurofibromatosis type 1, and multiple osteolytic lesions of both femurs: a previously undescribed association of findings.

Authors:  Francisco J Martínez-Tello; Palmira Manjón-Luengo; Manuel Martin-Pérez; Santiago Montes-Moreno
Journal:  Skeletal Radiol       Date:  2005-08-11       Impact factor: 2.199

3.  Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.

Authors:  Reinhard E Friedrich; Jozef Zustin; Andreas M Luebke; Thorsten Rosenbaum; Martin Gosau; Christian Hagel; Felix K Kohlrusch; Ilse Wieland; Martin Zenker
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

4.  Central giant cell granuloma of the jaws: clinical and radiological evaluation of 22 cases.

Authors:  Zhi-Jun Sun; Yu Cai; Roger A Zwahlen; Yun-Fei Zheng; Shi-Ping Wang; Yi-Fang Zhao
Journal:  Skeletal Radiol       Date:  2009-07-07       Impact factor: 2.199

5.  Computed tomography findings of an unusual maxillary sinus mass: brown tumor due to tertiary hyperparathyroidism.

Authors:  Canan Altay; Nezahat Erdoğan; Erdem Eren; Sedat Altay; Sebnem Karasu; Engin Uluç
Journal:  J Clin Imaging Sci       Date:  2013-11-28

6.  Nonfamilial cherubism: A case report and review of literature.

Authors:  Revati Deshmukh; Samir Joshi; Priya Nimish Deo
Journal:  J Oral Maxillofac Pathol       Date:  2017 Jan-Apr

7.  Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation.

Authors:  Natacha Kadlub; Quentin Sessiecq; Marion Mandavit; Aurore Coulomb L'Hermine; Cecile Badoual; Louise Galmiche; Ariane Berdal; Vianney Descroix; Arnaud Picard; Amélie E Coudert
Journal:  Orphanet J Rare Dis       Date:  2018-09-20       Impact factor: 4.123

8.  Central giant cells lesion: Report of a conservative management.

Authors:  Marina Rolo Pinheiro da Rosa; Juliana Lopes de Sá; Valber Barbosa Martins; Marcelo Vinícius de Oliveira
Journal:  Eur J Dent       Date:  2018 Apr-Jun

9.  Cherubism: A Rare Fibro-Osseous Disorder Characterized and Diagnosed by one Stop Imaging with Technetium-99m Methylene Diphosphonate Bone Scintigraphy Integrated with Single-Photon Emission Computed Tomography-Computed Tomography.

Authors:  Jaykanth Amalachandran; Thangalakshmi Sivathapandi; Shelley Simon; Indirani Elangoven; Patel Asra; Nikita S Rao; Meetashree Nayak
Journal:  Indian J Nucl Med       Date:  2019 Jan-Mar

10.  A possible case of cherubism in a 17th-century Korean mummy.

Authors:  Israel Hershkovitz; Mark Spigelman; Rachel Sarig; Do-Sun Lim; In Sun Lee; Chang Seok Oh; Hila May; Elisabetta Boaretto; Yi-Suk Kim; Soong Deok Lee; Nathan Peled; Myeung Ju Kim; Talya Toledano; Gila Kahila Bar-Gal; Dong Hoon Shin
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.